Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off
Roivant’s $14 million bet on a pulmonary hypertension drug from Bayer appears to have paid off as the…
#Germany #DE #Europe #EU #Europa #Bayer #Biotech #ClinicalData #FierceBiotechHomepage #lungdisease #PulmonaryHypertension #Roivant
https://www.europesays.com/germany/97400/